EPCAM and head and neck squamous cell carcinoma: Studies measuring PD-L1 expression in EpCAM-selected CTCs from locally advanced HPV-driven HNSCC receiving curative-intent CRT have also been done, and results indicated that over-expression of PD-L1 in CTCs at the end of treatment was associated with worse PFS and OS [65].